Loading...
MSN Laboratories Private Limited — Erlotinib Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #2 for Erlotinib · $529.7K export value · DGFT Verified
MSN Laboratories Private Limited is the #2 Indian exporter of Erlotinib with $529.7K in export value and 32 verified shipments. MSN Laboratories Private Limited holds a 19.8% market share in Erlotinib exports across 6 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $166.3K | 8 | 39.2% |
| PERU | $118.0K | 6 | 27.8% |
| CHILE | $81.8K | 8 | 19.3% |
| AUSTRALIA | $37.0K | 4 | 8.7% |
| UNITED STATES OF AMERICA | $21.3K | 2 | 5.0% |
| BRAZIL | $150 | 1 | 0.0% |
| MALTA | $37 | 3 | 0.0% |
MSN Laboratories Private Limited exports Erlotinib to 7 countries. The largest destination is UNITED STATES accounting for 39.2% of MSN Laboratories Private Limited's Erlotinib shipments, followed by PERU (27.8%) and CHILE (19.3%). These destinations reflect MSN Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | AUSTRALIA | $160.9K | 9 |
| MSN LABS PERU SAC CAL. | PERU | $53.3K | 3 |
| 'TO THE ORDER | CHILE | $43.3K | 2 |
| MSN LABS CHILE SPA RUT | CHILE | $38.5K | 1 |
| MSN LABS PERU SAC | PERU | $37.2K | 2 |
| NOVADOZ PHARMACEUTICALS LLC | UNITED STATES | $35.7K | 2 |
India exported $2.0M worth of Erlotinib through 336 shipments from 94 suppliers to 55 countries, serving 144 buyers globally. MSN Laboratories Private Limited contributes $529.7K to this total, accounting for 19.8% of India's Erlotinib exports. MSN Laboratories Private Limited ships Erlotinib to 7 countries through 13 buyers.
MSN Laboratories Private Limited's average Erlotinib shipment value is $16.6K per consignment, based on 32 shipments totaling $529.7K. The largest destination is UNITED STATES (39.2% of MSN Laboratories Private Limited's Erlotinib exports).
MSN Laboratories Private Limited ranks #2 among 94 Indian Erlotinib exporters with a 19.8% market share. The top 3 exporters are NATCO PHARMA LIMITED ($547.2K), MSN LABORATORIES PRIVATE LIMITED ($529.7K), VEXXA LIFESCIENCES PVT. LTD. ($253.4K). MSN Laboratories Private Limited processed 32 shipments to 6 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ERLOTINIB TAB 150MG 30 S NOVADOZ | $69.6K | 2 |
| ERLOTINIB TAB 150MG 30'S NOVADOZ | $44.0K | 2 |
| MSN PHARMACEUTICALS: ERLOTINIB 100MG (3X | $40.0K | 1 |
| MSN PHARMACEUTICAL PRODUCT NAME: ERLOTINIB 150MG 3x10's0 MSN -CL ALONG WITH 195NOS FREE SAMPLE | $38.5K | 1 |
| LOTYRO 150MG (3X10'S)-ERLOTINIB 150 MG MSN -PENOS | $27.8K | 1 |
| LOTYRO 150MG 3X10'S-ERLOTINIB 150MG MSN-PE | $27.6K | 1 |
| LOTYRO 150MG (3X10S)-ERLOTINIB 150 MG MSN-PENOS | $26.6K | 1 |
| MSN PHARMACEUTICALS - ERLOTINIB APOTEX 1 | $26.3K | 1 |
| ERLOTINIB TABLET 100 MG |
What MSN Laboratories Private Limited must comply with to export Erlotinib to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | NATCO PHARMA LIMITED | $547.2K | 11 | 3 | $49.7K |
| 2 | MSN LABORATORIES PRIVATE LIMITED ★ | $529.7K | 32 | 6 | $16.6K |
| 4 | VEXXA LIFESCIENCES PVT. LTD. | $253.4K | 16 | 1 | $15.8K |
| 3 | CIPLA LIMITED | $200.0K | 4 | 2 | $50.0K |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 71 | 21.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 65 | 19.3% |
| DELHI AIR CARGO ACC (INDEL4) | 34 | 10.1% |
| DELHI AIR | 27 | 8.0% |
| HYDERABAD AIR | 24 | 7.1% |
| Bombay Air | 21 | 6.3% |
| HYDERABAD ACC (INHYD4) | 18 | 5.4% |
| Bombay Air Cargo | 7 | 2.1% |
MSN Laboratories Private Limited also exports these advanced oncology products. Each links to the detailed product page.
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)
In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.
MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.
MSN Laboratories Private Limited exports 32 products worth $252.1M. Beyond Erlotinib, top products include Atorvastatin, Rosuvastatin, Ras, Oseltamivir, Calcium. View the complete MSN Laboratories Private Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Erlotinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for MSN Laboratories Private Limited's Erlotinib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MSN Laboratories Private Limited
Full Company Profile →
32 products · $252.1M total trade · 15 categories
| PERU |
| $27.6K |
| 1 |
| TO THE ORDER | UNITED STATES | $17.4K | 1 |
| APOTEX PTY LIMITED | AUSTRALIA | $8.3K | 2 |
| APOTEX PTY LTD | AUSTRALIA | $2.3K | 1 |
MSN Laboratories Private Limited supplies Erlotinib to 13 buyers globally. The largest buyer is TO THE ORDER OF (AUSTRALIA), followed by MSN LABS PERU SAC CAL. (PERU) and 'TO THE ORDER (CHILE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| $23.9K |
| 1 |
| LOTYRO 150MG (3X10'S)-ERLOTINIB 150 MG MSN-PENOS | $22.6K | 1 |
MSN Laboratories Private Limited exports 30 distinct Erlotinib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ERLOTINIB TAB 150MG 30 S NOVADOZ with 2 shipments worth $69.6K.
MSN Laboratories Private Limited ranks #2 among 94 Indian Erlotinib exporters. Average shipment value of $16.6K compared to the market average of $21.1K. The closest competitors by value are NATCO PHARMA LIMITED and VEXXA LIFESCIENCES PVT. LTD..
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 55+ countries, 144+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for MSN Laboratories Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Erlotinib. For current shipment-level data, contact TransData Nexus.